Transcode Therapeutics Inc (RNAZ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -34,661 | -21,218 | -16,362 | -12,085 | -16,755 |
| Depreciation Amortization | 114 | 69 | 65 | 51 | 535 |
| Income taxes - deferred | 226 | N/A | N/A | N/A | N/A |
| Other Working Capital | -211 | -325 | -680 | -455 | -352 |
| Other Operating Activity | 15,015 | 10,099 | 9,686 | 9,393 | 3,236 |
| Operating Cash Flow | $-19,516 | $-11,374 | $-7,291 | $-3,097 | $-13,336 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -7 | N/A | N/A | N/A | -22 |
| Net Acquisitions | 2 | N/A | N/A | N/A | N/A |
| Investing Cash Flow | $-4 | $N/A | $N/A | $N/A | $-22 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 8,855 | 8,855 | 8,855 | 8,855 | 16,401 |
| Other Financing Activity | 22,668 | -456 | 0 | 0 | 0 |
| Financing Cash Flow | $31,523 | $8,399 | $8,855 | $8,855 | $16,401 |
| Beginning Cash Position | 5,811 | 5,811 | 5,811 | 5,811 | 2,768 |
| End Cash Position | 17,814 | 2,836 | 7,375 | 11,569 | 5,811 |
| Net Cash Flow | $12,003 | $-2,975 | $1,564 | $5,758 | $3,044 |
| Free Cash Flow | |||||
| Operating Cash Flow | -19,516 | -11,374 | -7,291 | -3,097 | -13,336 |
| Capital Expenditure | -7 | N/A | N/A | N/A | -22 |
| Free Cash Flow | -19,523 | -11,374 | -7,291 | -3,097 | -13,358 |